WHO ICTRP trial
Novel biomarkers and the natriuretic peptide-cGMP signal pathway in the…
DRKS00036029 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00036029 |
|---|---|
| Public title | Novel biomarkers and the natriuretic peptide-cGMP signal pathway in the Cardiooncology |
| Scientific title | Novel biomarkers and the natriuretic peptide-cGMP signal pathway in the Cardiooncology |
| Primary sponsor | Universitätsklinikum Freiburg - Universitäts-Herzzentrum Freiburg-Bad Krozingen |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | I50.9;Heart failure, unspecified |
| Interventions | Group 1: Women with early breast cancer scheduled for chemotherapy that include therapy regimes with cardiotoxic potential. |
| Registration date | Jan 29, 2025 |
| Target size | 300 |
| Secondary IDs | 24-1103-S1;FRKS005149 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: